Chronic Kidney Disease - CKD Care in Stages I, II and III: Annual eGFR
The results below represent 25,078 patients with Stage I, II, or III Chronic Kidney Disease. Read More About This Measure
Chronic kidney disease (CKD) is a major public health problem. Improving outcomes for people with CKD requires a coordinated world-wide approach to prevention of adverse outcomes. Interventions during the earlier stages of kidney disease includes evaluation and management of co-morbid conditions, slowing progression of kidney disease, cardiovascular disease risk reduction, preventing and treating complications of CKD.
Disclaimer: Measures reported by WCHQ healthcare
organizations represent a specific aspect of care in relation to an
evidence-based standard, but are not clinical guidelines and do not establish
standards of care.
The National Kidney Foundation (NKF) recommends that patients should have one Estimated Glomerular Filtration Rate (eGFR) test annually, at a minimum.
This measure shows the percentage of people 18-85 years of age with a diagnosis of CKD in stage I, II or III, excluding those with CKD in stages IV or V or with End Stage Renal Disease (ESRD) who received an Estimated Glomerular Filtration Rate (eGFR) test during the measurement year.